VANESSA CUNNINGHAM GMYTERCO

Ms. VANESSA CUNNINGHAM GMYTERCO

Life Sciences, Pontifical Catholic University of Parana (PUCPR), Curitiba, Paraná, Brazil
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2023 in Acta Veterinaria Scandinavica
Verified
Journal Article
Open access
PDF file
VGVANESSA CUNNINGHAM GMYTERCO
VANESSA CUNNINGHAM GMYTERCO
TJTomasz Jagielski
Tomasz Jagielski
GBGustavo Baldasso
Gustavo Baldasso
LBLouise Helene Bacher
Louise Helene Bacher
MRMárcio Garcia Ribeiro
Márcio Garcia Ribeiro
MFMarconi Rodrigues de Farias
Marconi Rodrigues de Farias
Background: Protothecosis is a rare infectious disease caused by unicellular, achlorophyllous, microalgae of the genus Prototheca, ubiquitously distributed in nature. The algae are emerging pathogens, whose incidence is increasing in both human and animal populations and serious systemic infections related to this pathogen have been increasingly described in humans in recent years. After mastitis in dairy cows, canine protothecosis is the second most prevalent form of the protothecal disease in animals. Here, we report the first case of chronic cutaneous protothecosis due to P. wickerhamii in a dog in Brazil, successfully treated with a long-term therapy with itraconazole in pulse. Case presentation: Upon clinical examination, exudative nasolabial plaque, ulcered, and painful lesions in central and digital pads and lymphadenitis were observed in a 2-year-old mixed-breed dog, with a 4-month history of cutaneous lesions and contact with sewage water. Histopathological examination revealed intense inflammatory reaction, with numerous spherical to oval, encapsulated structures stained with Periodic Acid Schiff, compatible with Prototheca morphology. Tissue culture on Sabouraud agar revealed yeast-like, greyish-white colonies after 48 h of incubation. The isolate was subjected to mass spectrometry profiling and PCR-sequencing of the mitochondrial cytochrome b (CYTB) gene marker, leading to identification of the pathogen as P. wickerhamii. The dog was initially treated with oral itraconazole at a dosage of 10 mg/kg once daily. After six months, the lesions resolved completely, yet recurred shortly after cessation of therapy. The dog was then treated with terbinafine at a dose of 30 mg/kg, once daily for 3 months, with no success. The resolution of clinical signs, with no recurrence over a 36-months follow-up period, was achieved after 3 months of treatment with itraconazole (20 mg/kg) in pulse intermittently on two consecutive days a week. Conclusions: This report highlights the refractoriness of skin infections by Prototheca wickerhamii with therapies proposed in the literature and suggests a new treatment option with oral itraconazole in pulse dosing for long-term disease control successfully performed in a dog with skin lesions.


3 February 2025 in Veterinary Dermatology
Verified
Journal Article
Closed access
TFTássia Sell Ferreira
Tássia Sell Ferreira
WVWendy Roldán Villalobos
Wendy Roldán Villalobos
VGVANESSA CUNNINGHAM GMYTERCO
VANESSA CUNNINGHAM GMYTERCO
DFDiogo Simões Fonseca
Diogo Simões Fonseca
MFMarconi Rodrigues de Farias
Marconi Rodrigues de Farias

29 October 2026 in Veterinary Dermatology
Verified
Journal Article
Open access
CBCristiane Bazaga Botelho
Cristiane Bazaga Botelho
TFTássia Sell Ferreira
Tássia Sell Ferreira
VGVANESSA CUNNINGHAM GMYTERCO
VANESSA CUNNINGHAM GMYTERCO
CACaroline Alves
Caroline Alves
TNTim Nuttall
Tim Nuttall
JFJúlio Israel Fernandes
Júlio Israel Fernandes
Five dogs with head tilt, ataxia, incoordination or deafness without a history of otitis externa (OE) were diagnosed with otitis media by computed tomography (CT) or magnetic resonance imaging (MRI). Otoendoscopy showed possible tympanic membrane retraction with opaque, fibrotic membranes and advanced imaging showed middle ear involvement. The clinical significance requires further investigation.

18 April 2025 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
RGRaniere Gaertner
Raniere Gaertner
VGVANESSA CUNNINGHAM GMYTERCO
VANESSA CUNNINGHAM GMYTERCO
JSJulia So Severo
Julia So Severo
CACamilla O. R. Alcala
Camilla O. R. Alcala
MPMaicon Roberto Paulo
Maicon Roberto Paulo
MFMarconi Rodrigues de Farias
Marconi Rodrigues de Farias
(1): Background: This study aimed to evaluate the concentrations of four proteins for allergic patch testing (APT) in dogs, assessing sensitivity (SE), specificity (SP), negative predictive value (NPV), positive predictive value (PPV), reactions to adhesives/containers, and the safety of APT with food proteins in dogs. (2) Methods: For evaluation, 43 dogs were screened and divided into two groups: Group 1 consisted of 20 healthy dogs, and Group 2 included 23 dogs with canine atopic dermatitis (AD). Group 1 underwent allergic patch testing (APT) with beef, pork, chicken, and soy proteins at four different concentrations (100 mg, 250 mg, 500 mg, 1000 mg/0.2 mL). Of the 23 dogs included in Group 2, four did not undergo the elimination diet and were excluded, leaving 17 dogs in the study. They underwent an elimination diet (ED) and were evaluated using the pruritus visual analog scale (pVAS) and lesion scores (CADESI-4) before and after the ED (days 0 and 45). After the ED, Group 2 was subjected to APT (using the same proteins and concentrations as Group 1) and an oral provocation test (OPT) with the proteins used in the APT. The results of the OPT were used to assess the accuracy of the APT. (3) Results: In Group 1, one dog reacted to the APT. In Group 2, after 45 days of ED, of the 17 dogs included, 13 showed a reduction in pVAS and CADESI-4 scores (p < 0.05) and nine an improvement considered good to excellent. Of these, two showed irritant contact reactions to the APT chambers and were excluded, leaving 11 dogs that were reactive to APT, and the OPT increased pruritus (p < 0.05). Accuracy: Beef and chicken proteins at concentrations of 500 and 1000 mg/0.2 mL, and soy protein at 1000 mg/0.2 mL, achieved 100% SE, SP, PPV, and NPV. Pork protein at 1000 mg/0.2 mL achieved 100% SE, 83% SP, 83% PPV, and 100% NPV. (4) Conclusions: APT with beef and chicken proteins at 500 mg and 1000 mg/0.2 mL and soy protein at 1000 mg/0.2 mL, based on the results of this study, can be recommended for diagnosing adverse food reactions in dogs with AD.

22 June 2023 in Acta Veterinaria Scandinavica
Verified
Journal Article
Open access
PDF file
VGVANESSA CUNNINGHAM GMYTERCO
VANESSA CUNNINGHAM GMYTERCO
TJTomasz Jagielski
Tomasz Jagielski
GBGustavo Baldasso
Gustavo Baldasso
LBLouise Helene Bacher
Louise Helene Bacher
MRMarcio Garcia Ribeiro
Marcio Garcia Ribeiro
MFMarconi Rodrigues de Farias
Marconi Rodrigues de Farias